PRESERVE-β: Two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin

John Gerich, Philip Raskin, Lisa Jean-Louis, Das Purkayastha, Michelle A. Baron

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Fingerprint

Dive into the research topics of 'PRESERVE-β: Two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin'. Together they form a unique fingerprint.

Medicine & Life Sciences